BDNF and secondary progressive multiple sclerosis: In addition BDNF levels of untreated SPMS patients were lower than the levels in HC, even when adjusted for age, therefore we assume that medication was not the only responsible factor for the observed difference in BDNF serum levels, but there was no sufficient data to account for past treatment or treatment duration.